SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH H impact

Pelthos Therapeutics Inc. (PTHS) Q3 Zelsuvmi Revenue Rose 114% to $15.2M

Pelthos reported Q3 2026 Zelsuvmi net product revenue of $15.2M, up 114% from $7.1M in Q3 2025. It also announced a definitive merger agreement with Castle Creek on October 30, 2026.Material DetailsContext by AI AnalystThis is an early commercial-growth update alongside a proposed strategic combina…

PTHS

Related stories